Conference Coverage
Conference Coverage
When to suspect a severe skin reaction to an AED
NEW ORLEANS – Although most eruptions are benign, certain symptoms raise concerns about rare and potentially fatal antiepileptic drug reactions....
News
Minimally-invasive ICH lysis safely helps when clot adequately shrinks
HONOLULU – The primary endpoint from the phase 3 MISTIE III trial was neutral, apparently because clot lysis often fell short.
Conference Coverage
Autologous Hematopoietic Stem Cells May Treat Aggressive MS Effectively
BERLIN—Autologous hematopoietic stem cell transplantation (HSCT) could prevent disease activity and promote functional...
Conference Coverage
Interferon Beta May Not Affect Pregnancy Outcomes in MS
BERLIN—European registry data do not support the hypothesis that exposure to interferon beta before conception or during...
Conference Coverage
Deferoxamine does not improve 90-day outcomes after ICH
HONOLULU – The drug is safe, and data suggest that it could improve 180-day outcomes.
Conference Coverage
How Often Are Staring Spells Seizures?
CHICAGO—About half of staring spells referred to a new-onset seizure (NOS) clinic turn out to be epileptic seizures,...
Conference Coverage
Fund projects, not people to address gender bias in research funding
LONDON – Female investigators are less likely to secure research funding than men simply because they are women, according to research published...
Conference Coverage
Survey Identifies Variations in Management of Pediatric Posttraumatic Headache
CHICAGO—Child neurologists differ in their approach to diagnosing and managing posttraumatic...
Conference Coverage
Vaccination and antiviral treatment do not affect stroke risk following shingles
HONOLULU – Preventing shingles through vaccination might be the best method for preventing shingles-associated acute...
Conference Coverage
Treatment Challenges When Headache Has Central and Peripheral Involvement
ASHEVILLE, NC—Although neurologists tend to classify disorders as problems of either the CNS or the peripheral nervous...
Conference Coverage
Most U.S. tPA-eligible stroke patients now get treated within an hour
The most recent phase of the Target: Stroke program met its tPA delivery-time target in September 2018.